Adrian Oo
Impact in
- Pharmacology top 5%
- Pharmacological Effects of Natural Compounds
- Flavonoids in Medical Research
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
- Viral Infections and Vectors
Papers in
-
- SARS-CoV-2 and COVID-19 Research 4
- HIV/AIDS drug development and treatment 4
- Viral Infections and Vectors 4
-
- CRISPR and Genetic Engineering 3
- Co-authors
- Keivan Zandi (9 shared papers)Erik Arabyan (1 shared paper)Hovakim Zakaryan (1 shared paper)Sazaly Abu Bakar (4 shared papers)Baek Kim (14 shared papers)Pouya Hassandarvish (4 shared papers)Sazaly AbuBakar (4 shared papers)Boon‐Teong Teoh (2 shared papers)
- Journals
- Journal of Biological Chemistry (3 papers)Archives of Virology (2 papers)Journal of Antimicrobial Chemotherapy (1 paper)Scientific Reports (1 paper)Molecular Therapy (1 paper)
- Partner nations
- United StatesMalaysiaAustralia
In The Last Decade
Adrian Oo
26 papers receiving 901 citations
Adrian Oo's Hit Papers
Peers
Comparison fields: 5 of 98
- Pharmacology 134
- Infectious Diseases 246
- Virology 57
- Complementary and alternative medicine 97
- Computational Theory and Mathematics 177
Countries citing papers authored by Adrian Oo
This map shows the geographic impact of Adrian Oo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adrian Oo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adrian Oo more than expected).
Fields of papers citing papers by Adrian Oo
This network shows the impact of papers produced by Adrian Oo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adrian Oo. The network helps show where Adrian Oo may publish in the future.
Co-authors
The 25 scholars most cited alongside Adrian Oo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Flavonoids: promising natural compounds against viral infections Hit paper breakdown → | 2017 | 367 |
| 2 | 2021 | 104 | |
| 3 | 2018 | 78 | |
| 4 | 2017 | 65 | |
| 5 | 2016 | 62 | |
| 6 | 2020 | 50 | |
| 7 | 2016 | 31 | |
| 8 | 2019 | 24 | |
| 9 | 2021 | 21 | |
| 10 | 2012 | 19 | |
| 11 | 2020 | 14 | |
| 12 | 2022 | 12 | |
| 13 | 2021 | 11 | |
| 14 | 2022 | 9 | |
| 15 | 2021 | 8 | |
| 16 | 2023 | 7 | |
| 17 | 2017 | 7 | |
| 18 | 2024 | 6 | |
| 19 | 2022 | 6 | |
| 20 | 2023 | 6 |
About Adrian Oo
Adrian Oo is a scholar working on Infectious Diseases, Molecular Biology, Virology, Public Health, Environmental and Occupational Health and Immunology, having authored 27 papers that have together received 922 indexed citations. Recurring topics across this work include HIV Research and Treatment (8 papers), Mosquito-borne diseases and control (6 papers), Power System Optimization and Stability (4 papers), SARS-CoV-2 and COVID-19 Research (4 papers), Optimal Power Flow Distribution (4 papers), HIV/AIDS drug development and treatment (4 papers), Viral Infections and Vectors (4 papers) and CRISPR and Genetic Engineering (3 papers). The work is most often cited by research in Pharmacology (134 citations), Infectious Diseases (246 citations), Virology (57 citations), Complementary and alternative medicine (97 citations) and Computational Theory and Mathematics (177 citations). Adrian Oo has collaborated with scholars based in United States, Malaysia and Australia. Frequent co-authors include Keivan Zandi, Erik Arabyan, Hovakim Zakaryan, Sazaly Abu Bakar, Baek Kim, Pouya Hassandarvish, Sazaly AbuBakar, Boon‐Teong Teoh, Sing‐Sin Sam and Raymond F. Schinazi. Their work appears in journals such as Journal of Biological Chemistry, Archives of Virology, Journal of Antimicrobial Chemotherapy, Scientific Reports and Molecular Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.